click here to return to homepage
 
 

Acceava®, BinaxNOW®, Clearview®, RUBELLA-plus® are registered trademarks of the Inverness Medical family of companies

More Information

Clearview 25 hCG Combo

CLIA waivedClearview® 25 hCG Combo is a one-step test for the early detection of the pregnancy hormone, human chorionic gonadotropin (hCG).

Clearly different

Clearview® 25 hCG Combo uses a patented, innovative technology to provide highly sensitive and specific results for pregnancy. A sensitivity of 25 mIU/mL in urine and serum offers clear, consistent results.

  • Fast: single-step test provides positive results in as little as 1 minute

  • Easy: CLIA-waived (for urine), easy-to-use test

  • Reliable: highly sensitive assay with built-in controls ensures accuracy

  • Flexible: test can be used with either urine or serum samples

Clearly better

Early diagnosis with Clearview hCG enables proper planning, which reduces potential risks to the mother and fetus.

  • Earlier detection of pregnancy allows for improved patient care

  • Rapid results help prevent infection or contraindicated treatment

 

Clearview® 25 hCG Combo Test Procedure

Clearview 25hCG Combo Test Procedure

Add 3 drops of urine or serum to the Sample Well.

Result Window

Read result in 3 minutes for urine, or 5 minutes for serum. For full instructions, see package insert.


About Pregnancy

Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced by the developing placenta shortly after fertilization. In normal pregnancy, hCG can be detected in both urine and serum as early as 7 to 10 days after conception.1-4 hCG levels continue to rise very rapidly, frequently exceeding 100 mIU/mL by the first missed menstrual period, and peaking in the 100,000-200,000 mIU/mL range about 10-12 weeks into pregnancy.2-4 The appearance of hCG in both the urine and serum soon after conception, and its subsequent rapid rise in concentration during early gestational growth, make it an excellent marker for the early detection of pregnancy.

References

  1. Batzer FR. “Hormonal evaluation of early pregnancy”, Fertil. Steril. 1980; 34(1): 1-13

  2. Catt KJ, ML Dufau, JL Vaitukaitis “Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyte”, J. Clin. Endocrinol. Metab. 1975; 40(3): 537-540

  3. Braunstein GD, J Rasor, H. Danzer, D Adler, ME Wade “Serum human chorionic gonadotropin levels throughout normal pregnancy”, Am. J. Obstet. Gynecol. 1976; 126(6): 678-681

  4. Lenton EA, LM Neal, R Sulaiman “Plasma concentration of human chorionic gonadotropin from the time of implantation until the second week of pregnancy”, Fertil. Steril. 1982; 37(6): 773-778

Specifications
Order No. 92225
Qty: 40 Tests
CPT*: 81025, 84703
CLIA: Waived, Non-waived
Contact: (800) 257-9525
Accessories: 92218: hCG Controls
Clearview 25 hCG Combo
Product Demonstration
Useful Downloads
Product Brochure
Reimbursement
Look up CPT & ICD-9 codes, coverage policies, and state by state Medicare reimbursement information at: www.codemap.com/
inverness
 or call the CodeMap Hotline: 847.381.5465 x5, or email: customerservice@
codemap.com


*It is always the provider's responsibility to establish appropriate coding & charges.
For technical information including: CLSI procedures, Material Safety Data Sheets (MSDS) and package inserts,
call Technical Services at 800-257-9525





Please note that individual products may have different specifications in various markets. Also, some products may not be available in all markets worldwide. The products on this website are available in the United States of America.